Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2022
Pharmaron acquires Aesica Pharmaceuticals' Cramlington site
Pharmaron announced that it had acquired Aesica Pharmaceuticals Limited's Cramlington site in the United Kingdom from the Recipharm group. The site provides commercial active pharmaceutical ingredient manufacturing capacity.
2022
Pharmaron acquires the Cramlington Site
Pharmaron announced that it had acquired Aesica Pharmaceuticals Limited’s Cramlington Site from the Recipharm group.
2021
Pharmaron promotes Katherine Lee to chief business officer
Pharmaron promoted Katherine Lee to chief business officer, effective October 1, 2021. In the role, she will continue to lead and integrate the company’s global business development strategies and operations.
2021
Pharmaron announces agreement to acquire the ABL site
Pharmaron announced a definitive agreement to acquire Allergan Biologics Limited’s biomanufacturing site in Liverpool from AbbVie for US$118.7 million in cash. The transaction was expected to close in the second quarter of 2021, subject to customary closing conditions.
2020
Pharmaron acquires Absorption Systems
Pharmaron announced that it had acquired 100% of the equity of US-based Absorption Systems for up to $137.5 million in cash.
2019
Pharmaron lists shares in Hong Kong
Pharmaron listed on the Hong Kong Stock Exchange on November 28, 2019, issuing 116.5 million shares and raising approximately HK$4.34 billion.